Replies to post #10492 on GTC Biotherapeutics (fka GTCB)

[jessellivermore]

Excellent Dew,

Now if GTC is on the ball they will up date this slide, and some one from the company or from LEO will be getting in touch with Dr. Cuomo in Naples, Italy, and arrange to provide Atryn for his anticipated clinical study on thrombotic strokes....A double blind study sounds about right.....

[doofus_king]

Nice graphic. However, I don't recall any reference to "CABG-COG = Cognitive deficit following coronary bypass" in anything from the company. I do recall it from a post a few back. Is that your criteria?

[vinmantoo]

Dew,

Thanks for the chart of possible uses for rATIII in different acquired deficiences. When the partnership finally does materialize, I would like to see them fully fund trials in one or more of them. The point is we need to expand rATIII past only sepsis since I don't know if GTCB could survive if the sepsis news is bad.

Vinny